Abstract:When looking for examples of the effects of population ageing, economic growth, and rural-to-urban migration on trends in obesity and diabetes, there is no better country to refer to than China.1Tian Y Jiang C Wang M et al.BMI, leisure-time physical activity, and physical fitness in adults in China: results from a series of national surveys, 2000–14.Lancet Diabetes Endocrinol. 2016; 4: 487-497Summary Full Text Full Text PDF PubMed Scopus (157) Google Scholar Its legacy reporting systems and near obsession with data collection has meant that there is intimate and reliable knowledge obtained from massive and well-maintained datasets of both temporal trends and their drivers—including the effects of migration.2Bi Y Wang L Xu Y et al.for the 2012 China Noncommunicable Disease and Risk Factor Surveillance in Migrant Workers Study GroupDiabetes-related metabolic risk factors in internal migrant workers in China: a national surveillance study.Lancet Diabetes Endocrinol. 2016; 4: 125-135Summary Full Text Full Text PDF PubMed Scopus (28) Google Scholar In a country with a prevalence of diabetes between 9·7% and 11·6% (up from 2·5% in 1994),3Ma RCW Lin X Jia W Causes of type 2 diabetes in China.Lancet Diabetes Endocrinol. 2014; 2: 980-991Summary Full Text Full Text PDF PubMed Scopus (112) Google Scholar which equates to the largest number of people with diabetes in one country, this information is absolutely essential for health-system planning. Researchers in China have also clearly shown that following the so-called western-centric model of thinking about diabetes does not suit a Chinese population;4Yang W Weng J Early therapy for type 2 diabetes in China.Lancet Diabetes Endocrinol. 2014; 2: 992-1002Summary Full Text Full Text PDF PubMed Scopus (24) Google Scholar BMI cutoffs for obesity, HbA1C cutoffs for diabetes, and treatments for diabetes have all been redefined for use in a Chinese setting after meticulous research. Thus—as could perhaps be appropriate to a country progressing from lower to higher income status—research in China has been tailored to address questions necessary to improve its own population's health. Additional benefits could been seen globally, however, because China acts as a clear lens through which similar transitions occurring in other countries can be viewed and interpreted, especially those with poor availability of data, for example in sub-Saharan Africa.5NCD Risk Factor Collaboration (NCD-RisC)Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants.Lancet. 2016; 387: 1513-1530Summary Full Text Full Text PDF PubMed Scopus (2329) Google Scholar Nevertheless, as time has progressed, Chinese researchers have looked outside the fields of epidemiology and public health and embraced the wide range of research from subcellular and genetics to clinical trials.6Jia W Diabetes research in China: making progress.Lancet Diabetes Endocrinol. 2016; (published online June 28.)http://dx.doi.org/10.1016/S2213-8587(16)30094-8Google Scholar They have also done this without neglecting the need to answer unaddressed questions of public health relevance, including the necessity to find solutions to ensure that appropriate treatment and prevention is delivered in an affordable way.7Jia W Tong N Diabetes prevention and continuing health-care reform in China.Lancet Diabetes Endocrinol. 2015; 3: 840-842Summary Full Text Full Text PDF PubMed Scopus (15) Google Scholar This range of diabetes research from China is beautifully encapsulated in the set of 35 abstracts that The Lancet Diabetes & Endocrinology are publishing to coincide with presentations at the Chinese Diabetes Society meeting (Xiamen, China; Nov 16–19, 2016). From more than 100 high-quality abstracts that were submitted, after peer review and much discussion, we selected ten for oral presentations and 25 for poster presentations. The selected abstracts span fields from genetics to health systems, epidemiology, and clinical trials; and look at diabetes, its risk factors, and its interactions with other diseases. All of the abstracts selected have potentially tangible benefits for human health. These abstracts are a celebration of the excellent diabetes research being done in China. WJ declares no competing interests. HW and JD declare no competing interests.

Ten Clinical Studies in China Contributing to the Global Research on Prevention and Control of Diabetes Mellitus

Paediatric type 2 diabetes in China—Pandemic, progression, and potential solutions

Progress in diabetes research in China.

A Brief Talk on the Current Situation Prevention and Treatment Strategies of Diabetes in China

Diabetes Research in China: Making Progress.

Trends in Prevalence, Awareness, Treatment, and Control of Diabetes Mellitus in Mainland China from 1979 to 2012

China—leading the Way in Diabetes Research

A thorough analysis of diabetes research in China from 1995 to 2015: current scenario and future scope

The future of prevention and treatment of diabetes with nutrition in China

Prevalence, Awareness, Treatment and Control of Diabetes Mellitus in a Chinese Population

Abstract 011: Prevalence and Control of Diabetes in Chinese Adults: the China Metabolic Risk Factor Study

Glycemic Control Rate of T2DM Outpatients in China: A Multi-Center Survey

Clinical and Basic Studies of GLP-1 Receptor Agonists for the Treatment of Diabetes in China

Current Status of Diabetes Prevention and Control in China and Early-Stage Intervention Strategies

Diabetes in China Part 2: Prevention, Challenges, and Progress

Epidemiological situation of diabetes prevalence in China

The Diabetes Epidemic in China: an Integrated Review of National Surveys

Clinical research progress on β-cell dysfunction in T2DM development in the Chinese population

Preventing Diabetes:Problems and Prospects

Standards of medical care for type 2 diabetes in China 2019

Diabetes Prevalence and Determinants in Adults in China Mainland from 2000 to 2010: A Systematic Review